The field of antimicrobial susceptibility testing (AST) and resistance detection is rapidly evolving to address the global threat posed by antimicrobial resistance. In recent years, a ...
For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately 5% of all TB cases worldwide. Extensively drug-resistant (XDR-TB) strains have been detected in at ...
The global Antimicrobial Susceptibility Testing (AST) market, valued at approximately USD 3.42 billion in 2023, is projected to reach USD 5.35 billion by 2032, registering a steady compound annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback